AMP Capital Investors Ltd grew its holdings in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 1.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,023 shares of the medical equipment provider’s stock after buying an additional 700 shares during the quarter. AMP Capital Investors Ltd’s holdings in Zimmer Biomet were worth $7,378,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in ZBH. Bessemer Group Inc. increased its stake in shares of Zimmer Biomet by 21.1% in the second quarter. Bessemer Group Inc. now owns 4,297 shares of the medical equipment provider’s stock valued at $552,000 after buying an additional 750 shares in the last quarter. IFP Advisors Inc increased its stake in shares of Zimmer Biomet by 22.4% in the second quarter. IFP Advisors Inc now owns 2,077 shares of the medical equipment provider’s stock valued at $267,000 after buying an additional 380 shares in the last quarter. Global X Management Co. LLC increased its stake in shares of Zimmer Biomet by 41.6% in the second quarter. Global X Management Co. LLC now owns 6,315 shares of the medical equipment provider’s stock valued at $811,000 after buying an additional 1,854 shares in the last quarter. Trexquant Investment LP acquired a new stake in shares of Zimmer Biomet in the second quarter valued at $231,000. Finally, Canada Pension Plan Investment Board increased its stake in shares of Zimmer Biomet by 7.7% in the second quarter. Canada Pension Plan Investment Board now owns 51,861 shares of the medical equipment provider’s stock valued at $6,659,000 after buying an additional 3,700 shares in the last quarter. Institutional investors own 86.24% of the company’s stock.

A number of brokerages have recently weighed in on ZBH. Jefferies Group restated a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet in a research note on Friday, November 3rd. Stifel Nicolaus reiterated a “hold” rating and issued a $120.00 price objective on shares of Zimmer Biomet in a research report on Friday, November 3rd. Gabelli began coverage on Zimmer Biomet in a research report on Thursday, August 24th. They issued a “buy” rating and a $142.00 price objective for the company. SunTrust Banks reiterated a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet in a research report on Monday, October 2nd. Finally, TheStreet lowered Zimmer Biomet from a “b-” rating to a “c+” rating in a research report on Friday, November 24th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $134.05.

Zimmer Biomet Holdings Inc (ZBH) traded down $0.02 during trading on Thursday, hitting $113.52. The stock had a trading volume of 2,815,500 shares, compared to its average volume of 1,362,485. The firm has a market cap of $22,988.79, a price-to-earnings ratio of 14.07, a P/E/G ratio of 1.76 and a beta of 1.15. Zimmer Biomet Holdings Inc has a 52 week low of $100.81 and a 52 week high of $133.49. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78.

Zimmer Biomet (NYSE:ZBH) last posted its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). The company had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet had a return on equity of 16.29% and a net margin of 8.36%. Zimmer Biomet’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.79 earnings per share. equities research analysts expect that Zimmer Biomet Holdings Inc will post 8.03 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “AMP Capital Investors Ltd Increases Stake in Zimmer Biomet Holdings Inc (ZBH)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.watchlistnews.com/amp-capital-investors-ltd-increases-stake-in-zimmer-biomet-holdings-inc-zbh/1764106.html.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.